Bipartisan Group of Senators Launch Effort to Stop Patent Gaming & Increase Access to Lower-Cost Drugs

Washington, D.C.—In a bipartisan effort to encourage competition in the prescription drug marketplace and put an end to the harmful patent strategies that block new drugs from coming to market, U.S. Senators Susan Collins (R-ME) and Tim Kaine (D-VA) introduced the Biologic Patent Transparency Act.  The legislation was cosponsored by Senators Rob Portman (R-OH), Jeanne Shaheen (D-NH), Mike Braun (R-IN), and Debbie Stabenow (D-MI).

 

Read More...

Senators Collins, King Announce $789,659 Climate Change Research Grant for Gulf of Maine Research Institute

WASHINGTON, D.C.  – U.S. Senators Susan Collins (R-Maine) and Angus King (I-Maine) today announced that National Science Foundation (NSF) has awarded the Gulf of Maine Research Institute (GMRI) $789,659 in grant funding to examine the impact of a warming climate on growth and population patterns in cod and lobster. The study will also document marine habitat shifts across the northwest Atlantic caused by rising temperatures.

 

Read More...

Senator Collins Joins Bipartisan Group in Introducing Legislation to Strengthen Cybersecurity Risk Management at Publicly Traded Companies

 

Washington, D.C. - In an effort to better protect customers, increase transparency for investors, and ensure public companies are prioritizing cybersecurity and data privacy, U.S. Senator Susan Collins (R-ME) joined Senators Jack Reed (D-RI), Mark Warner (D-VA), John Kennedy (R-LA), and Doug Jones (D-AL) in introducing the Cybersecurity Disclosure Act of 2019.  Senator Collins is a member of the Senate Intelligence Committee. 

 

Read More...

Pages